Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Vanguard International High Dividend Yield ETF (VYMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Vanguard International High Dividend Yield ETF — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.27B), while Vanguard International High Dividend Yield ETF trades at $102.18 (market cap $22.80B). The key difference: Vanguard International High Dividend Yield ETF is far larger — about 10× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Vanguard International High Dividend Yield ETF is more actively traded (748,441 versus 4,179,659). Which is the better fit depends on your goals.
| SLS | VYMI | |
|---|---|---|
Market Cap | $2.27B | $22.80B |
Volume | 4,179,659 | 748,441 |
Sector | Health | Broad Market / Factor |
52-Week High | $15.46 | $107.13 |
52-Week Low | $1.39 | $82.92 |
Enterprise Value | $2.14B | — |
Typical Hold Time | — | 50 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VYMI trades at $100.23, down 1.11% with a bearish technical signal from moving averages. The ETF offers international diversification with a focus on high dividend yields, recently announcing a $0.82 dividend payment scheduled for September 2026. Recent institutional buying activity from firms like Envestnet and Corient Private Wealth indicates growing institutional interest despite the current technical weakness.
The outlook remains constructive given VYMI's strong historical performance (14.13% 5-year average annual return) and dividend growth potential. Key risks include global market volatility and currency fluctuations affecting international holdings. The ETF's financials-heavy portfolio (43.6% allocation) positions it to benefit from rising global interest rates, though this concentration also increases sector-specific risk exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Vanguard International High Dividend Yield ETF
VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.
Read more on VYMI →
